Materials. Molecular biology manipulations were carried out using standard techniques.
Expression construct for His 6 -BcmE. Chromosomal DNA from C. botulinum was used as the template for PCR amplification of bcmE (CLB_0812). The forward and reverse primers were designed with NheI and XhoI restriction sites (indicated in underlined font), respectively, as BcmE FP: 5′-GGGTAGCATATGTTTTCAGGGGATGAACCCAAAC -3′ and BcmE RP: 5′-CCCCTACTCGAGTTATTGTTGTAAATATTCAGTAATAATTTTC-3′. The forward primer was also designed to remove the native signal sequence. The amplified product containing the gene was excised from an agarose gel, purified and digested with NdeI and XhoI, repurified, and then ligated into similarly digested and purified pOHT. The final construct encodes a gene product without the native signal sequence. Instead, the leader sequence from E. coli ompA followed by six histidine residues and a TEV protease recognition sequence are appended to the N-terminus of the encoded protein. Competent E. coli MachI cells were transformed with the sample. Cells were plated on LB agar (1.5%) supplemented with 50 µg/mL kanamycin to select for positive clones. Subsequently, clones were screened by colony PCR and the desired gene products were confirmed by DNA sequencing.
Expression and purification of His 6 -Bcm proteins. Electrocompetent Escherichia coli
BL21(DE3) cells were prepared using standard methods. The cells were freshly transformed with the pET construct containing the appropriate N-terminal hexa-histidine bcm fusion gene. Single colony transformants were grown aerobically for 12-15 h at 37 °C in 20 mL of LB medium supplemented with 50 µg/mL kanamycin (LB-kan). Cells from the starter culture were added to 2 L of LB-kan, and the culture was grown aerobically at 37 °C until the A 600 was 0.6-0.8. UV-Vis spectra of substrate and product peaks were also collected and assessed.
In vitro activity of BcmA. CMP (500 µM) and CH 2 H 4 folate (1.5 mM) were incubated with BcmA (10 µM) in 50 mM HEPES, pH 7.5, containing 150 mM KCl and β-mercaptoethanol (20 mM). Reactions were incubated in darkness for 2 h at 25 °C. Control reactions identical to those described above but lacking CMP, CH 2 H 4 folate, β-mercaptoethanol, or BcmA were also prepared. The samples (50 µL) were diluted 3-fold with assay buffer and then the protein was removed by centrifugal ultrafiltration through a 10 kDa MWCO membrane (Pall Life Sciences).
A 50 µL aliquot of the filtrate was analyzed by reverse-phase HPLC.
In vitro activity of BcmB. BcmB (10 µM) was added to the BcmA reaction products and incubated in darkness for 2 h at 25 °C. The sample (50 µL) was diluted 3-fold with assay buffer and then the proteins were removed by centrifugal ultrafiltration through a 10 kDa MWCO membrane. A 50 µL aliquot of the filtrate was analyzed by reverse-phase HPLC. To assess the substrate specificity of BcmB, CMP (500 µM) and CH 2 H 4 folate (1.5 mM) were incubated with BcmB (10 µM) in 50 mM HEPES, pH 7.5, containing 150 mM KCl and β-mercaptoethanol (20 mM). Reactions were incubated in darkness for 2 h at 25 °C. Control reactions identical to those described above but lacking CMP, CH 2 H 4 folate, β-mercaptoethanol, or BcmB were also prepared. The samples (50 µL) were diluted, filtered, and analyzed as described above.
In vitro activity of BcmC. SAM (2 mM) and 7 (0.5 mM) were incubated with BcmC (10 µM) in 50 mM HEPES, pH 7.5, containing 150 mM KCl for 2 h at 25 °C. The samples (50 µL) were diluted 3-fold with assay buffer and then the proteins were removed by centrifugal ultrafiltration through a 10 kDa MWCO membrane. A 50 µL aliquot of the filtrate was analyzed by reversephase HPLC.
In vitro activity of BcmD. Bacimethrin was synthesized as previously described. [5] [6] [7] [8] Bacimethrin (0.5 mM) was incubated with ATP (4 mM) and MgCl 2 (8 mM) in the presence of BcmD (10 µM) in 50 mM HEPES, pH 7.5, containing 150 mM KCl for 2 h at 25 °C. Control reactions identical to those described above but lacking bacimethrin, ATP, or BcmD were also prepared.
The samples (50 µL) were diluted 3-fold with assay buffer and then the proteins were removed by centrifugal ultrafiltration through a 10 kDa MWCO membrane. A 50 µL aliquot of the filtrate was analyzed by reverse-phase HPLC.
Phosphatase treatment of reaction products. Reaction mixtures were prepared, diluted, and filtered as described above. The filtrate (~ 150 µL) was incubated with 1 µL of calf intestinal alkaline phosphatase (CIP; 10,000 units/mL) for 30 min at 37 °C. The CIP was removed by centrifugal ultrafiltration (10 kDa MWCO membrane) and aliquots of the filtrate (50 µL) were analyzed by reverse-phase HPLC.
Reconstitution of the entire bacimethrin biosynthetic pathway in vitro. CMP (500 µM) and CH 2 H 4 folate (1.5 mM) were incubated with BcmA (10 µM) in 50 mM HEPES, pH 7.5, containing 150 mM KCl and β-mercaptoethanol (20 mM). The sample was incubated in darkness for 2 h at 25 °C (to protect the light-sensitive folate). Next, BcmB (10 µM) was added and the reaction was incubated in darkness for 2 h at 25 °C. Subsequently, SAM (2 mM) and BcmC (10 µM) were added and the reaction mixture was incubated in darkness for 2 h at 25 °C. Finally, ATP (4 mM), MgCl 2 (8 mM), and BcmD (10 µM) were added and the reaction mixture was incubated in darkness for 2 h at 25 °C. Control reactions identical to those described above but lacking, variously, CMP, β-mercaptoethanol, and one or more enzymes were also prepared. The samples (50 µL) were diluted 3-fold with assay buffer and then the proteins were removed by centrifugal ultrafiltration through a 10 kDa MWCO membrane. A 50 µL aliquot of the filtrate was analyzed by reverse-phase HPLC.
In vitro activity of BcmE as monitored by NMR. 1 H NMR spectra were acquired on a Varian INOVA 500 MHz instrument equipped with an autoswitchable probe and a Z-axis pulsed field gradient. 2′-Methoxythiamin (16) was synthesized as previously described. 9 For assessment of the enzyme activity, the substrate (13 or 16, 10 mM) was treated with BcmE (300 nM) in a solution prepared from 0.2 mL of 100 mM potassium phosphate buffer, pH 8.0, 0. 
